{"id":787045,"date":"2023-09-29T08:13:10","date_gmt":"2023-09-29T12:13:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/"},"modified":"2023-09-29T08:13:10","modified_gmt":"2023-09-29T12:13:10","slug":"aspira-womens-health-to-present-at-the-bioventure-nexus-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/","title":{"rendered":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference"},"content":{"rendered":"

\nThe conference is taking place on October 5-6, 2023, in Los Angeles, CA
\n<\/h2>\n
\n

AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) — Aspira Women\u2019s Health Inc. (\u201cAspira\u201d or \u201cthe Company\u201d) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women\u2019s health diagnostic tools for gynecologic diseases, today announced that Nicole Sandford, Chief Executive Officer, will present a brief corporate overview at the BioVenture Nexus Conference at 4:30 pm PDT on October 5, 2023. The conference is taking place at the JW Marriott \u2013 The Ritz Carlton DTLA on October 5-6, 2023, in Los Angeles, CA. To register for the conference, click HERE.<\/a>\u00a0\u00a0<\/p>\n

\n About\u00a0Aspira\u00a0Women\u2019s\u00a0Health\u00a0Inc.\u00a0<\/strong>
\n
Aspira Women\u2019s Health Inc. is transforming women\u2019s gynecological health with the discovery, development, and commercialization of innovative testing options for women of all races and ethnicities, starting with ovarian cancer.\u00a0\u00a0\u00a0<\/p>\n

Our ovarian cancer risk assessment portfolio is marketed to healthcare providers as OvaSuiteSM<\/sup>, which includes OvaWatchSM<\/sup>, a non-invasive, blood-based test intended for use in the initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses for which surgical intervention may be either premature or unnecessary. With a negative predictive value (NPV) of 99%, OvaWatch allows physicians to confidently rule out ovarian cancer malignancy and choose the appropriate clinical management for the right patient at the right time. Ova1Plus\u00ae<\/sup>\u00a0combines our FDA-cleared products, Ova1\u00ae<\/sup>\u00a0and Overa\u00ae<\/sup>, to detect risk of ovarian malignancy in women with adnexal masses planned for surgery.\u00a0\u00a0\u00a0<\/p>\n

EndoCheckSM<\/sup>, Aspira\u2019s first-of-its-kind non-invasive diagnostic test for endometriosis, is currently in development. Visit our website for more information at\u00a0www.aspirawh.com<\/a>.\u00a0\u00a0<\/p>\n

\n
\n Investor Relations Contact:<\/em>
\n <\/strong>
\n
Monique Kosse\u00a0
Managing Director
LifeSci Advisors, LLC
Tel: 212-915-3820
monique@lifesciadvisors.com<\/em><\/strong><\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

The conference is taking place on October 5-6, 2023, in Los Angeles, CA AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) — Aspira Women\u2019s Health Inc. (\u201cAspira\u201d or \u201cthe Company\u201d) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women\u2019s health diagnostic tools for gynecologic diseases, today announced that Nicole Sandford, Chief Executive Officer, will present a brief corporate overview at the BioVenture Nexus Conference at 4:30 pm PDT on October 5, 2023. The conference is taking place at the JW Marriott \u2013 The Ritz Carlton DTLA on October 5-6, 2023, in Los Angeles, CA. To register for the conference, click HERE.\u00a0\u00a0 About\u00a0Aspira\u00a0Women\u2019s\u00a0Health\u00a0Inc.\u00a0 Aspira Women\u2019s Health Inc. is transforming women\u2019s gynecological health with the discovery, development, and commercialization … <\/p>\n

Continue reading “Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-787045","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The conference is taking place on October 5-6, 2023, in Los Angeles, CA AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) — Aspira Women\u2019s Health Inc. (\u201cAspira\u201d or \u201cthe Company\u201d) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women\u2019s health diagnostic tools for gynecologic diseases, today announced that Nicole Sandford, Chief Executive Officer, will present a brief corporate overview at the BioVenture Nexus Conference at 4:30 pm PDT on October 5, 2023. The conference is taking place at the JW Marriott \u2013 The Ritz Carlton DTLA on October 5-6, 2023, in Los Angeles, CA. To register for the conference, click HERE.\u00a0\u00a0 About\u00a0Aspira\u00a0Women\u2019s\u00a0Health\u00a0Inc.\u00a0 Aspira Women\u2019s Health Inc. is transforming women\u2019s gynecological health with the discovery, development, and commercialization … Continue reading "Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-29T12:13:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference\",\"datePublished\":\"2023-09-29T12:13:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/\",\"name\":\"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==\",\"datePublished\":\"2023-09-29T12:13:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/","og_locale":"en_US","og_type":"article","og_title":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk","og_description":"The conference is taking place on October 5-6, 2023, in Los Angeles, CA AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) — Aspira Women\u2019s Health Inc. (\u201cAspira\u201d or \u201cthe Company\u201d) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women\u2019s health diagnostic tools for gynecologic diseases, today announced that Nicole Sandford, Chief Executive Officer, will present a brief corporate overview at the BioVenture Nexus Conference at 4:30 pm PDT on October 5, 2023. The conference is taking place at the JW Marriott \u2013 The Ritz Carlton DTLA on October 5-6, 2023, in Los Angeles, CA. To register for the conference, click HERE.\u00a0\u00a0 About\u00a0Aspira\u00a0Women\u2019s\u00a0Health\u00a0Inc.\u00a0 Aspira Women\u2019s Health Inc. is transforming women\u2019s gynecological health with the discovery, development, and commercialization … Continue reading \"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-29T12:13:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference","datePublished":"2023-09-29T12:13:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/","name":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==","datePublished":"2023-09-29T12:13:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDcwNCM1ODM4NjY2IzUwMDA0NTYzNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-to-present-at-the-bioventure-nexus-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aspira Women\u2019s Health to Present at the BioVenture Nexus Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/787045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=787045"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/787045\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=787045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=787045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=787045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}